Cargando…

Treatment of ursodeoxycholic acid with glucocorticoids and immunosuppressants may improve the long-term survival rate in primary biliary cholangitis patients

Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease. The clinical effectiveness of ursodeoxycholic acid (UDCA) plus glucocorticoids and/or immunosuppressants remains controversial in PBC patients. The study aimed to compare the efficacy of monotherapy and combination therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zi-Long, Jin, Rui, Hao, Mei, Xie, Yan-Di, Liu, Zhi-Cheng, Wang, Xiao-Xiao, Feng, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678505/ https://www.ncbi.nlm.nih.gov/pubmed/36401422 http://dx.doi.org/10.1097/MD.0000000000031395

Ejemplares similares

Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis: A meta-analysis
por: Wang, Zi-Long, et al.
Publicado: (2022)

Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine: A protocol for systematic review and meta analysis
por: Chen, Xing, et al.
Publicado: (2020)

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis
por: Gauss, Annika, et al.
Publicado: (2016)

Platelet count to spleen thickness ratio is related to histologic severity of primary biliary cholangitis
por: Wang, Zhongfeng, et al.
Publicado: (2018)

Case–Control Study on Prednisolone Combined With Ursodeoxycholic Acid and Azathioprine in Pure Primary Biliary Cirrhosis With High Levels of Immunoglobulin G and Transaminases: Efficacy and Safety Analysis
por: Fang, Yu-Qing, et al.
Publicado: (2014)

Primary sclerosing cholangitis with increased immunoglobulin G4 levels: A case report
por: Chen, Qing-Ling, et al.
Publicado: (2019)

Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis
por: Fujinaga, Yukihisa, et al.
Publicado: (2021)

Benefit of glucosyl Hesperidin in patients with primary biliary cholangitis: A multicenter, open-label, randomized control study
por: Moriya, Kei, et al.
Publicado: (2022)

A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
por: Ma, Hong, et al.
Publicado: (2016)

A case report of motesanib-induced biliary sludge formation causing obstructive cholangitis with acute pancreatitis treated by endoscopic sphincterotomy
por: Song, Jay, et al.
Publicado: (2016)

Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
por: Shu, Yanyun, et al.
Publicado: (2021)

External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: Cheung, Angela C., et al.
Publicado: (2018)

Associating pancreaticostomy and biliary-irrigation for staged pancreaticoduodenectomy approach to pancreatic intraductal papillary mucinous neoplasm with recurrent cholangitis and severe jaundice: A case report
por: Dai, Chao, et al.
Publicado: (2016)

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
por: Cançado, Guilherme Grossi Lopes, et al.
Publicado: (2022)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Value of posttransplant protocol biopsies in 2 biliary autoimmune liver diseases: A step toward personalized immunosuppressive treatment
por: Vannas, Marko, et al.
Publicado: (2022)

Comparison on Response and Dissolution Rates Between Ursodeoxycholic Acid Alone or in Combination With Chenodeoxycholic Acid for Gallstone Dissolution According to Stone Density on CT Scan: Strobe Compliant Observation Study
por: Lee, Jae Min, et al.
Publicado: (2015)

Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study
por: Kotb, Magd Ahmed, et al.
Publicado: (2020)

Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report
por: Zhao, Dan-Tong, et al.
Publicado: (2020)

Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis
por: Zimmer, Vincent, et al.
Publicado: (2016)

Hepatic Angiosarcoma May Have Fair Survival Nowadays
por: Huang, Neng-Chyan, et al.
Publicado: (2015)

Diabetes mellitus is associated with a higher rate of acute cholangitis among patients with common bile duct stones: A retrospective study
por: Khoury, Tawfik, et al.
Publicado: (2022)

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis
por: Martinez-Gili, Laura, et al.
Publicado: (2023)

The efficacy and safety of different doses of glucocorticoid for autoimmune hepatitis: A systematic review and meta-analysis
por: Zhang, Chi, et al.
Publicado: (2019)

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review
por: Li, Xuan, et al.
Publicado: (2020)

A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
por: Li, Chunlei, et al.
Publicado: (2022)

Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
por: Yang, Chunmei, et al.
Publicado: (2022)

Von Hippel-Lindau disease involving pancreas and biliary system: A rare case report
por: Zhi, Xu-Ting, et al.
Publicado: (2017)

Analysis of clinical characteristics and treatment of immunoglobulin G4-associated cholangitis: A retrospective cohort study of 39 IAC patients
por: Xiao, Jianchun, et al.
Publicado: (2018)

The Effects of Different Preoperative Biliary Drainage Methods on Complications Following Pancreaticoduodenectomy
por: Huang, Xin, et al.
Publicado: (2015)

Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: de Veer, Rozanne C., et al.
Publicado: (2022)

Ursodeoxycholic Acid Treatment–Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis
por: de Veer, Rozanne C., et al.
Publicado: (2023)

Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis: A Case Report and Literature Review
por: Zhang, Yi-An, et al.
Publicado: (2015)

Survival Benefit and Safety of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy
por: Yang, Kun, et al.
Publicado: (2014)

Effectiveness of bezafibrate and ursodeoxycholic acid in patients with primary biliary cholangitis: a meta-analysis of randomized controlled trials
por: Agrawal, Rohit, et al.
Publicado: (2019)

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
por: Harms, Maren H, et al.
Publicado: (2020)

Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid
por: Ding, Dawei, et al.
Publicado: (2022)

Clinicopathological features of choledocholithiasis patients with high aminotransferase levels without cholangitis: Prospective comparative study
por: Huh, Cheal Wung, et al.
Publicado: (2016)

Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5j5fcsrr7to9599rd95r1l3sen